Biomedical Engineering Reference
In-Depth Information
beam radiation in patients with inoperable esophageal cancer. Gastroenterology
132
(4),
A417-A417 (2007)
13. Tyler, B.M., Hdeib, A., Caplan, J., Legnani, F.G., Fowers, K.D., Brem, H., Jallo, G., Pradilla,
G.: Delayed onset of paresis in rats with experimental intramedullary spinal cord gliosar-
coma following intratumoral administration of the paclitaxel delivery system OncoGel
laboratory investigation. J. Neurosurg. Spine
16
(1), 93-101 (2012). doi
:
10.3171/2011.9.sp
14. Torres, A.J., Zhu, C., Shuler, M.L., Pannullo, S.: Paclitaxel delivery to brain tumors
from hydrogels: a computational study. Biotechnol. Prog.
27
(5), 1478-1487 (2011).
doi:
10.1002/btpr.665
15. Tyler, B., Renard, V., Kaiser, S., Fowers, K., Brem, H.: 20 Gy radiotherapy with locally deliv-
ered OncoGel((R)) (6.0-mg/ml paclitaxel) significantly prolongs survival in an experimental
rodent glioma model. J. Neurooncol.
87
(2), 243-244 (2008)
16. Tyler, B., Fowers, K.D., Li, K.W., Recinos, V.R., Caplan, J.M., Hdeib, A., Grossman, R.,
Basaldella, L., Bekelis, K., Pradilla, G., Legnani, F., Brem, H.: A thermal gel depot for local
delivery of paclitaxel to treat experimental brain tumors in rats laboratory investigation. J.
Neurosurg.
113
(2), 210-217 (2010). doi:
10.3171/2009.11.jns08162
17. Appel, E.A., Rowland, M.J., Loh, X.J., Heywood, R.M., Watts, C., Scherman, O.A.:
Enhanced stability and activity of temozolomide in primary glioblastoma multiforme cells
with cucurbit[n]uril. Chem. Commun.
48
(79), 9843-9845 (2012). doi:
10.1039/c2cc35131e
18. Vellimana, A.K., Recinos, V.R., Hwang, L., Fowers, K.D., Li, K.W., Zhang, Y.G., Okonma,
S., Eberhart, C.G., Brem, H., Tyler, B.M.: Combination of paclitaxel thermal gel depot with
temozolomide and radiotherapy significantly prolongs survival in an experimental rodent gli-
oma model. J. Neurooncol.
111
(3), 229-236 (2013). doi
:
10.1007/s11060-012-1014-1
19. Linghu, E., Matthes, K., Mino-Kenudson, M., Brugge, W.R.: Feasibility of endoscopic ultra-
sound-guided OncoGel (ReGel/paclitaxel) injection into the pancreas in pigs. Endoscopy
37
(11), 1140-1142 (2005). doi:
10.1055/s-870224
20. Vukelja, S.J., Anthony, S.P., Arseneau, J.C., Berman, B.S., Cunningham, C.C., Nemunaitis,
J.J., Samlowski, W.E., Fowers, K.D.: Phase 1 study of escalating-dose OncoGel((R))
(ReGel((R))/paclitaxel) depot injection, a controlled-release formulation of paclitaxel,
for local management of superficial solid tumor lesions. Anticancer Drugs
18
(3), 283-289
(2007). doi
:
10.1097/CAD.0b013e328011a51d
21. Tishler, R.B., Busse, P.M., Norris, C.M., Rossi, R., Poulin, M., Thornhill, L., Costello, R.,
Peters, E.S., Colevas, A.D., Posner, M.R.: An initial experience using concurrent paclitaxel
and radiation in the treatment of head and neck malignancies. Int. J. Radiat. Oncol. Biol.
Phys.
43
(5), 1001-1008 (1999). doi:
10.1016/s0360-3016(98)00533-1
22. Tishler, R.B., Lamppu, D.M.: The interaction of taxol and vinblastine with radiation induc-
tion of p53 and p21(WAF1/CIP1). Br. J. Cancer
74
, S82-S85 (1996)
23. Zanelli, G.D., Quaia, M., Robieux, I., Bujor, L., Santarosa, M., Favaro, D., Spada, A., Caffau,
C., Gobitti, C., Trovo, M.G.: Paclitaxel as a radiosensitiser: a proposed schedule of adminis-
tration based on in vitro data and pharmacokinetic calculations. Eur. J. Cancer
33
(3), 486-
492 (1997). doi
:
10.1016/s0959-8049(96)00478-9
24. Kamangar, F., Dores, G.M., Anderson, W.F.: Patterns of cancer incidence, mortality, and
prevalence across five continents: defining priorities to reduce cancer disparities in differ-
ent geographic regions of the world. J. Clin. Oncol.
24
(14), 2137-2150 (2006). doi:
10.1200/
25. Williams, R.: Discontinued drugs in 2011: oncology drugs. Expert Opin. Investig. Drugs
22
(1), 9-34 (2013). doi:
10.1517/13543784.2013.739605